Arovea Formulations Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 16-11-2024
- Paid Up Capital ₹ 0.10 M
as on 16-11-2024
- Company Age 3 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 22.05 Cr
as on 16-11-2024
- Revenue 380.81%
(FY 2023)
- Profit 92.70%
(FY 2023)
- Ebitda -772.18%
(FY 2023)
- Net Worth -8.51%
(FY 2023)
- Total Assets 444.12%
(FY 2023)
About Arovea Formulations
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹22.05 Cr.
Ronakkumar Patel and Pravinbhai Patel serve as directors at the Company.
- CIN/LLPIN
U24299GJ2021PTC123370
- Company No.
123370
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Jun 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Arovea Formulations?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ronakkumar Patel  | Director | 17-Jun-2021 | Current |
| Pravinbhai Patel | Director | 17-Jun-2021 | Current |
Financial Performance of Arovea Formulations.
Arovea Formulations Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 380.81% increase. The company also saw a substantial improvement in profitability, with a 92.7% increase in profit. The company's net worth dipped by a decrease of 8.51%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Arovea Formulations?
Unlock access to Arovea Formulations's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Sol Derma Pharmaceuticals Private LimitedActive 16 years 4 monthsRonakkumar Patel and Pravinbhai Patel are mutual person
Charges (Loans)
₹220.50 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 22.05 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Apr 2022 | Hdfc Bank Limited | ₹6.00 Cr | Open |
| 16 Feb 2022 | Hdfc Bank Limited | ₹16.05 Cr | Open |
How Many Employees Work at Arovea Formulations?
Unlock and access historical data on people associated with Arovea Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Arovea Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Arovea Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.